Uruguay Senate Approves New Bill To Regulate Access To Medical Cannabis

By Silvia Muñoz, ICCI.

To help put a definitive end to persisting illicit cannabis markets, Uruguay's senate has passed a new bill to regulate medical marijuana. The bill, "A Comprehensive Law for the Promotion and Access to Medical and Therapeutic Cannabis," was introduced into Congress by the "Ir" sector of the “Frente Amplio” party, and approved unanimously.

This bill aims to promote and regulate the population’s access to cannabis and cannabinoid-containing medical products. According to the Montevideo Portal, although the standardized pharmaceutical versions are already regulated by the drug law and can be purchased at pharmacies, the price of these products is beyond the reach of most patients.

Compounded Cannbis Compounds

The new bill also presents guidelines for pharmaceutical compounding. This means that, with the help of doctors, patients will have access to specific prescriptions, perpared speficially to treat their ailments and diverse pathologies. The law will also seek to promote good manufacturing practices (GMPs) that are easy to replicate.

See Also: Moms, Presidents And Open Letters: The Tango For Cannabis Legalization And Home Growing In Latin America

The Institute for Cannabis Regulation and Control in Uruguay (IRCCA) will establish a system of certification and quality control, while the Ministry of Public Health will implement a program of Medicinal Cannabis and Therapeutic Use to include these treatments within the Integrated National System of Health.

Alejandro Zavala, deputy of the Ir Sector explained to the Montevideo Portal that this new bill structures, organizes and proposes the regularization of the existing handicraft products to guarantee the quality of what is produced. He also highlights that the bill will not only give accessible cannabis to the population at a reasonable price but as well a controlled product with good quality.

See Also: Brazil Regulates Sale Of Medical Marijuana Products

Editor's note: The following publicly traded companies have interests in Uruguay:

Aurora Cannabis Inc ACB

Auxly Cannabis Group Inc CBWTF

Khiron Life Sciences Corp KHRNF

Silvia Muñoz is a cannabis industry insider and Responsible for Government Affairs LATAM in the International Cannabis and Cannabinoids Institute in Czech Republic.

Photo of a cannabis grow in Uruguay, by Javier Hasse. In the picture, Leandro Martinelli, Head of R&D at YVY - Medical Cannabis Uruguay, at an experimental grow site.

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has only been edited for clarity and actionability.

Posted In: UruguayUruguy CannabisCannabisNewsMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.